Privia Health selling stockholders offer 42.56M shares; company receives no proceeds

Privia Health Group, Inc.

Underwriting agreement with Goldman Sachs for secondary offering of 42,561,196 shares of common stock.
Offering closed May 8, 2023; company received no proceeds from sale by selling stockholders.
Registration statement on Form S-3ASR (File No. 333-268394) filed November 15, 2022, with prospectus supplement.
Total estimated expenses of $595,185 for the issuance to be paid by the company.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Privia Health Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC (effective 2023-05-04).

Action: entry
Agreement: underwriting
Counterparty: Goldman Sachs & Co. LLC
Effective: 2023-05-04

Exact text from the filing

On May 4, 2023, Privia Health Group, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC as underwriter (the “Underwriter”) and the selling stockholders listed on Schedule I thereto (the “Selling Stockholders”) with respect to an underwritten offering by the Selling Stockholders of 42,561,196 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, held by such Selling Stockholders.

View on SEC.gov

Browse all material agreements →

Privia Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-016401

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.